Key Events This Week
2 Mar: New 52-week low at Rs.822.05 amid sustained downtrend
2 Mar: Significant gap down opening of 7.93%
4 Mar: Continued decline with Rs.857.00 close (-1.58%)
6 Mar: Week closes at Rs.865.95 with a modest 1.06% gain

Epigral Ltd is Rated Sell by MarketsMOJO
2026-03-07 10:10:38Epigral Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 Dec 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 07 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article
Epigral Ltd Opens with Significant Gap Down Amid Market Concerns
2026-03-02 13:34:28Epigral Ltd, a specialty chemicals company, opened the trading session with a pronounced gap down, reflecting heightened market concerns following a series of negative performance indicators and a downgrade in its mojo grade. The stock’s opening price plunged by 7.93%, marking a fresh 52-week low and continuing a downward trend that has persisted over the past week.
Read full news article
Epigral Ltd Stock Falls to 52-Week Low of Rs 822.05 Amid Continued Downtrend
2026-03-02 13:05:06Epigral Ltd, a key player in the Specialty Chemicals sector, has touched a new 52-week low of Rs.822.05 today, marking a significant decline amid a sustained downward trend. The stock’s performance continues to lag behind its sector and broader market indices, reflecting ongoing pressures on its financial metrics and market valuation.
Read full news article
Epigral Ltd Stock Falls to 52-Week Low of Rs 901.6 Amid Continued Downtrend
2026-02-27 14:36:20Epigral Ltd, a player in the Specialty Chemicals sector, recorded a fresh 52-week low of Rs.901.6 today, marking a significant milestone in its ongoing price decline. The stock has underperformed its sector and broader market indices, reflecting a challenging period for the company’s equity performance.
Read full news article









